Obesity Trial, Recruiting NCT05791604 Sponsor: Children's Hospital of Fudan University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05791604
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children with Prader-Willi syndrome (before their teenage years) who have been confirmed to have the condition through genetic testing
  • Children who meet the medical definition of obesity
  • Children who are not currently taking part in, and have not taken part in, any other research study in the past three months
  • Children whose parents agree to participate and have signed a consent form on their behalf

Who may not be able to join:

  • Children who are already using weight loss methods outside of this trial, such as taking weight loss medications or any medicines known to cause changes in body weight
  • Children who have taken antibiotics for 3 or more days within the month before the study begins
  • Children who have taken probiotic supplements for 3 or more days within the month before the study begins
  • Children with significant liver or kidney problems, as shown by certain blood test results being more than twice the upper limit of the hospital's normal range (confirm with trial site)
  • Children with digestive conditions that affect how their body absorbs food — for example, severe ongoing diarrhoea, severe constipation, serious gut inflammation, active stomach ulcers, or acute gallbladder inflammation
  • Children who have had surgery within the year before the study starts, not including appendix or hernia operations
  • Children who have Hepatitis B, active tuberculosis, HIV/AIDS, or other infectious diseases
  • Children who have a mental health condition and are currently taking psychiatric medications such as antidepressants

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wei Lu, Dr, Children's Hospitial of Fudan Univeristy

Phone: 86-021-64933281

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital of Fudan University
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
31 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Body mass index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov